Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse

Christopher N Nguyen; Swaminathan P Iyer; Roberto N Miranda; Carlos A Torres-Cabala; Jonathan L Curry; Penny Fang; Valencia D Thomas; Auris O Huen

doi:10.1016/j.jdcr.2021.09.005

Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse

JAAD Case Rep. 2021 Sep 20:17:34-37. doi: 10.1016/j.jdcr.2021.09.005. eCollection 2021 Nov.

Authors

Christopher N Nguyen¹, Swaminathan P Iyer², Roberto N Miranda³, Carlos A Torres-Cabala^{4

5}, Jonathan L Curry⁴, Penny Fang⁶, Valencia D Thomas⁵, Auris O Huen⁵

Affiliations

¹ School of Medicine, Baylor College of Medicine, Houston, Texas.
² Department of Lymphoma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
³ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁵ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁶ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Keywords: ALCL; ALCL, anaplastic large cell lymphoma; ALK, anaplastic lymphoma kinase; C-ALCL; CD30+ LPD; CHOP, cyclophosphamide, Adriamycin, vincristine, prednisone; CHP-BV, cyclophosphamide, doxorubicin, prednisone, and brentuximab vedotin; CTCL; LPD, lymphoproliferative disorder; cutaneous lymphoma.

Publication types

Case Reports